Abstract The coronavirus disease 2019 (COVID-19) virus is spreading rapidly, and scientists
are endeavoring to discover drugs for its efficacious treatment in China. Chloroquine …

The coronavirus SARS-CoV-2 which causes the COVID-19 disease is a global public health
emergency. Coronavirus are single-stranded positive-sense RNA viruses and their genome …

In the context of the current coronavirus disease 2019 (COVID-19) pandemic, we conducted
a meta-analysis on the effects of chloroquine derivatives in patients, based on unpublished …

Covid-19 is a new coronavirus disease first described in December 2019. This respiratory
illness is severe and potentially fatal. Severe cases make up to 15%, lethality ranges …

Chloroquine and hydroxychloroquine are quinoline derivatives used to treat malaria. To
date, these medications are not approved for the treatment of viral infections, and there are …

There is a long trail of research studies testing the in vitro and in vivo efficacy of chloroquine
and its derivatives in treating and preventing infection by various coronavirus species. More …

Currently, there is no widely acceptable and proven effective treatment for coronavirus
disease 2019 (COVID‐19). Colchicine has been shown to offer a benefit in reducing the …

BackgroundClozapine, an antipsychotic with unique efficacy in treatment-resistant
psychosis, is associated with increased susceptibility to infection, including pneumonia …

Abstract Coronavirus virus disease 2019 (COVID-19) is a viral infectious disease caused by
the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), actually considered as …

What is known and Objective Non‐clinical studies suggest that chloroquine (CQ) and
hydroxychloroquine (HCQ) have antiviral activities. Early clinical reports of successful HCQ …